WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. Lyon (France): International Agency for Research on Cancer; 2024. (WHO classification of tumours series, 5th ed.; vol. 11) https://publications.iarc.who.int/637.

Laurent C, Adélaïde J, Guille A, et al. High-grade follicular lymphomas exhibit clinicopathologic, cytogenetic, and molecular diversity extending beyond grades 3A and 3B. Am J Surg Pathol. 2021;45(10):1324–36.

Article  PubMed  Google Scholar 

Katzenberger T, Kalla J, Leich E, et al. A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood. 2009;113(5):1053–61.

Article  CAS  PubMed  Google Scholar 

Mann RB, Berard CW. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol. 1983;1(2):187–92.

Article  CAS  PubMed  Google Scholar 

Rimsza LM, Li H, Braziel RM, et al. Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort. Haematologica. 2018;103(4):e151–e3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kroft SH. Stratification of follicular lymphoma: time for a paradigm shift? Am J Clin Pathol. 2019;151(6):539–41.

Article  PubMed  Google Scholar 

Koch K, Richter J, Hanel C, et al. Follicular lymphoma grade 3B and diffuse large B‑cell lymphoma present a histopathological and molecular continuum lacking features of progression/ transformation. Haematologica. 2022;107(9):2144–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siddiqi IN, Friedman J, Barry-Holson KQ, et al. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations. Mod Pathol. 2016;29(6):570–81.

Article  CAS  PubMed  Google Scholar 

Nann D, Ramis-Zaldivar JE, Müller I, et al. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. Blood Adv. 2020;4(22):5652–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmatz AI, Streubel B, Kretschmer-Chott E, et al. Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol. 2011;29(11):1445–51.

Article  PubMed  Google Scholar 

Willemze R, Kerl H, Sterry W, Berti E, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European organization for research and treatment of cancer. Blood. 1997;90(1):354–71.

CAS  PubMed  Google Scholar 

Quintanilla-Martinez L, Sander B, Chan JK, et al. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia. Virchows Arch. 2016;468(2):141–57.

Article  CAS  PubMed  Google Scholar 

Sehn LH, Salles G. Diffuse large B‑cell lymphoma. N Engl J Med. 2021;384(9):842–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salaverria I, Martin-Guerrero I, Wagener R, et al. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood. 2014;123(8):1187–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Montesinos-Rongen M, Brunn A, Bentink S, et al. Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia. 2008;22(2):400–5.

Article  CAS  PubMed  Google Scholar 

Belhouachi N, Xochelli A, Boudjoghra M, et al. Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire. Blood Adv. 2020;4(7):1357–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferry JA, Harris NL, Young RH, et al. Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol. 1994;18(4):376–90.

Article  CAS  PubMed  Google Scholar 

Pilichowska M, Pittaluga S, Ferry JA, et al. Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood Adv. 2017;1(26):2600–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011;117(18):4726–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Natkunam Y, Gratzinger D, Chadburn A, et al. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal? Blood. 2018;132(18):1871–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Melody M, Epperla N, Shouse G, et al. Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T‑cell therapy. Blood Adv. 2024;8(10):2327–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ohmoto A, Fuji S. Rapid T‑cell lymphoma progression associated with immune checkpoint inhibitors. Expert Rev Hematol. 2023;16(7):535–41.

Article  CAS  PubMed  Google Scholar 

Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720–48.

Article  PubMed  PubMed Central  Google Scholar 

Campo E, Jaffe ES, Cook JR, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2022;140(11):1229–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karube K, Satou A, Kato S. New classifications of B‑cell neoplasms: a comparison of 5th WHO and international consensus classifications. Int J Hematol. 2024; https://doi.org/10.1007/s12185-024-03781-5.

Article  PubMed  Google Scholar